Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Stroke Rate Variation and Anticoagulation Benefit in Atrial Fibrillation.

Joosten LPT, van Doorn S, Rutten FH, Geersing GJ.

Ann Intern Med. 2019 Jun 4;170(11):816-817. doi: 10.7326/L19-0129. No abstract available.

PMID:
31158860
2.

Ruling out pulmonary embolism across different subgroups of patients and healthcare settings: protocol for a systematic review and individual patient data meta-analysis (IPDMA).

Geersing GJ, Kraaijpoel N, Büller HR, van Doorn S, van Es N, Le Gal G, Huisman MV, Kearon C, Kline JA, Moons KGM, Miniati M, Righini M, Roy PM, van der Wall SJ, Wells PS, Klok FA.

Diagn Progn Res. 2018 Jul 2;2:10. doi: 10.1186/s41512-018-0032-7. eCollection 2018.

3.

[Towards 'the best DOAC'?]

van Doorn S, Rutten FH, Geersing GJ.

Ned Tijdschr Geneeskd. 2019 Mar 21;163. pii: D3524. Dutch.

PMID:
30945829
4.

[Frameworks for responsible anticoagulation care: a contribution to a collective view].

Folkeringa RJ, Geersing GJ, Cate HT.

Ned Tijdschr Geneeskd. 2018 Nov 30;162. pii: D2811. Dutch.

PMID:
30570924
5.

Effectiveness of CHA2DS2-VASc based decision support on stroke prevention in atrial fibrillation: A cluster randomised trial in general practice.

van Doorn S, Rutten FH, O'Flynn CM, Oudega R, Hoes AW, Moons KGM, Geersing GJ.

Int J Cardiol. 2018 Dec 15;273:123-129. doi: 10.1016/j.ijcard.2018.08.096. Epub 2018 Sep 8.

PMID:
30224261
6.

Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation: a prospective cohort study in the Netherlands.

van Doorn S, Tavenier A, Rutten FH, Hoes AW, Moons KGM, Geersing GJ.

BMJ Open. 2018 Aug 23;8(8):e021681. doi: 10.1136/bmjopen-2018-021681.

7.
8.

Opportunistic screening for heart failure with natriuretic peptides in patients with atrial fibrillation: a meta-analysis of individual participant data of four screening studies.

van Doorn S, Geersing GJ, Kievit RF, van Mourik Y, Bertens LC, van Riet EES, Boonman-de Winter LJ, Moons KGM, Hoes AW, Rutten FH.

Heart. 2018 Aug;104(15):1236-1237. doi: 10.1136/heartjnl-2017-312781. Epub 2018 Mar 16.

PMID:
29549089
9.
10.

The effects of misclassification in routine healthcare databases on the accuracy of prognostic prediction models: a case study of the CHA2DS2-VASc score in atrial fibrillation.

van Doorn S, Brakenhoff TB, Moons KGM, Rutten FH, Hoes AW, Groenwold RHH, Geersing GJ.

Diagn Progn Res. 2017 Nov 16;1:18. doi: 10.1186/s41512-017-0018-x. eCollection 2017.

11.

Integrated management of atrial fibrillation including tailoring of anticoagulation in primary care: study design of the ALL-IN cluster randomised trial.

van den Dries CJ, Oudega R, Elvan A, Rutten FH, van de Leur SJCM, Bilo HJG, Hoes AW, Moons KGM, Geersing GJ.

BMJ Open. 2017 Sep 18;7(9):e015510. doi: 10.1136/bmjopen-2016-015510.

12.

Predictive performance of the CHA2DS2-VASc rule in atrial fibrillation: a systematic review and meta-analysis.

van Doorn S, Debray TPA, Kaasenbrood F, Hoes AW, Rutten FH, Moons KGM, Geersing GJ.

J Thromb Haemost. 2017 Jun;15(6):1065-1077. doi: 10.1111/jth.13690. Epub 2017 May 9. Review.

13.

Clinical characteristics associated with diagnostic delay of pulmonary embolism in primary care: a retrospective observational study.

Hendriksen JM, Koster-van Ree M, Morgenstern MJ, Oudega R, Schutgens RE, Moons KG, Geersing GJ.

BMJ Open. 2017 Mar 9;7(3):e012789. doi: 10.1136/bmjopen-2016-012789.

14.

Multi-faceted implementation strategy to increase use of a clinical guideline for the diagnosis of deep venous thrombosis in primary care.

Kingma AEC, van Stel HF, Oudega R, Moons KGM, Geersing GJ.

Fam Pract. 2017 Aug 1;34(4):446-451. doi: 10.1093/fampra/cmw066.

PMID:
27471223
15.

Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH.

Kearon C, Ageno W, Cannegieter SC, Cosmi B, Geersing GJ, Kyrle PA; Subcommittees on Control of Anticoagulation, and Predictive and Diagnostic Variables in Thrombotic Disease.

J Thromb Haemost. 2016 Jul;14(7):1480-3. doi: 10.1111/jth.13336. Epub 2016 Jun 7. No abstract available.

16.

Ruling Out Pulmonary Embolism in Primary Care: Comparison of the Diagnostic Performance of "Gestalt" and the Wells Rule.

Hendriksen JM, Lucassen WA, Erkens PM, Stoffers HE, van Weert HC, Büller HR, Hoes AW, Moons KG, Geersing GJ.

Ann Fam Med. 2016 May;14(3):227-34. doi: 10.1370/afm.1930.

17.

Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care.

Hendriksen JM, Geersing GJ, Lucassen WA, Erkens PM, Stoffers HE, van Weert HC, Büller HR, Hoes AW, Moons KG.

BMJ. 2015 Sep 8;351:h4438. doi: 10.1136/bmj.h4438. Review.

18.

Response to Richard Schreiber: diagnosing pulmonary embolism in frail older adults out of the hospital.

Schouten HJ, Geersing GJ, Oudega R, van Delden JJ, Moons KG, Koek HL.

J Am Geriatr Soc. 2015 May;63(5):1049-50. doi: 10.1111/jgs.13419. No abstract available.

PMID:
25989582
19.

The impending epidemic of chronic cardiopulmonary disease and multimorbidity: the need for new research approaches to guide daily practice.

Geersing GJ, de Groot JA, Reitsma JB, Hoes AW, Rutten FH.

Chest. 2015 Oct;148(4):865-869. doi: 10.1378/chest.14-3172. Review.

PMID:
25856418
20.

[The physician and the collector of diagnoses].

Geersing GJ.

Ned Tijdschr Geneeskd. 2015;159:A8808. Dutch.

PMID:
25850457

Supplemental Content

Loading ...
Support Center